SYNE3 and head and neck squamous cell carcinoma: Specifically, we found that in KIRC (P < 0.001, HR = 0.58, Kaplan–Meier), LUAD (P = 0.011, HR = 0.67), CESC (P = 0.02, HR = 0.57) and squamous cell carcinoma of head and neck (HNSC) (P = 0.046, HR = 0.76), patients with high SYNE3 expression survive longer than others with low SYNE3 expression level.